Lilly Ventures ( LaunchBio )
Lilly Ventures serves as an investor and strategic partner to the global biotech ecosystem. Lilly Ventures makes investments to move the innovation needle in novel areas of science.
LaunchBio, Browne Consulting, and Silicon Valley Bank, a division of First Citizens Bank, are pleased to announce their next Investor Connect virtual event with Lilly Ventures.
They deploy customized engagement models to co-invest with world-class syndicate partners and offer counsel and connections within its global network with the goal of maximizing a company’s scientific impact.
Applications will be selected based on meeting the following criteria:
Geography:
Open to investments globally
Company type:
Seed, Series A stage investments in therapeutics companies within and outside the core areas of focus for Eli Lilly and Company
Areas of Interest:
- Biologics
- Cell therapies
- CRISPR-based therapies
- Gene therapies
- Protein-based therapies
- Regenerative Medicine
- RNA-based therapeutics
- Small molecules
- Vaccines
Therapeutic areas of interest include, but are not limited to:
- Open to all target organs/systems and a broad range of therapeutic areas, including cardiology, endocrinology, hematology, oncology, neurology, immunology, hematology and pulmonology
Stage:
Companies seeking funding for Seed, Series A
